As demonstrated in Figure 5A, PRRSV-N protein levels decreased as the dose of recombinant sISG15 increased, suggesting that the ISG15 treatment of PAMs conferred resistance to infection or inhibition of PRRSV replication. The gene discussed is ISG15; the disease is infection.